Marco Quaglia

The MEST score provides earlier risk prediction in lgA nephropathy

Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich et al. · Kidney International · 2015 · 279 citations · Full text

Mest Score, Glomerulonephritis, Medicine +7

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology · 2021 · 217 citations · Full text

Pediatric desmoid tumor: retrospective analysis of 63 cases.

Lawrence Faulkner, Steven I. Hajdu, Uma Kher et al. · Journal of Clinical Oncology · 1995 · 171 citations

Risk management of renal biopsy: 1387 cases over 30 years in a single centre

Piero Stratta, Caterina Canavese, Mónica Marengo et al. · European Journal of Clinical Investigation · 2007 · 122 citations

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Rosanna Coppo, Graziella D’Arrigo, Giovanni Tripepi et al. · Nephrology Dialysis Transplantation · 2018 · 105 citations · Full text